PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trialFlorian Lordick, J. R. Siewert, Hinrich Wieder et al.|The Lancet Oncology|2007Cited by 808
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954Christoph Schuhmacher, Peter M. Schlag, Stephan Gretschel et al.|Journal of Clinical Oncology|2010Cited by 714
Metabolic Imaging Predicts Response, Survival, and Recurrence in Adenocarcinomas of the Esophagogastric JunctionKatja Ott, Jörg‐Rüdiger Siewert, Wolfgang Weber et al.|Journal of Clinical Oncology|2006Cited by 464
Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective TrialKatja Ott, Wolfgang Weber, U. Fink et al.|Journal of Clinical Oncology|2003Cited by 320